Patricia Drake
Corporate Officer/Principal chez TREVENA, INC.
Fortune : 41 760 $ au 31/05/2024
Profil
Patricia Drake is currently the Chief Commercial Officer & Senior Vice President at Trevena, Inc. Prior to this, she was the Chief Executive Officer & Managing Director at MSD Finland Oy from 2019 to 2021, and the Chief Commercial Officer at Sesen Bio, Inc. in 2021.
She completed her undergraduate degree at Wichita State University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
TREVENA, INC.
0,58% | 14/12/2023 | 107 078 ( 0,58% ) | 41 760 $ | 31/05/2024 |
Postes actifs de Patricia Drake
| Sociétés | Poste | Début |
|---|---|---|
| TREVENA, INC. | Corporate Officer/Principal | 11/11/2021 |
Anciens postes connus de Patricia Drake
| Sociétés | Poste | Fin |
|---|---|---|
| CARISMA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/09/2021 |
| MSD Finland Oy | Directeur Général | 01/05/2021 |
Formation de Patricia Drake
| Wichita State University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TREVENA, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Sesen Bio, Inc. is a late-stage clinical company, which engages in the development of targeted fusion protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver, and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA. | Health Technology |
| MSD Finland Oy |
